Evidence map›Paper›PMID 21265047›Full record

ArticleJournal of Zhejiang University. Science. B2011

A relative quantitative method to detect OCT4A gene expression by exon-junction primer and locked nucleic acid-modified probe.

Jian-jun Ren, Xing-kai Meng

Abstract read
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jian-jun RenDepartment of General Surgery, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Xing-kai Meng

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOCT4A has been known to play a critical role in the maintenance of pluripotency of embryonic stem cells. Recent research has shown that OCT4A is also expressed in partial tumor cell lines and tissues. This study is aimed to develop a real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay for relative quantitative detection of OCT4A mRNA and discrimination from OCT4B, pseudogene, and genomic contaminations.

methodsA locked nucleic acid (LNA)-modified probe was designed to discern the single base difference 352A/C to identify OCT4A mRNA. An exon-junction primer was designed to avoid false positive caused by genomic contaminations. In addition, a house keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was measured in parallel to normalize the differences between samples and operations.

resultsExperiments showed that the newly established RT-PCR assay amplified the OCT4A mRNA selectively; OCT4A analogues gave negative signals. Cell lines nTERA-2 and HepG2 showed positive results in OCT4A expression, while for HeLa and 293 cell lines, as well as primary peripheral blood mononuclear cells (PBMCs), OCT4A expression was negative. Additionally, the relative quantity of OCT4A mRNA was calculated by cycle threshold (C(t)) method and house keeping gene normalization.

conclusionsThis technique proved to be effective for relative quantitation of OCT4A mRNA with high specificity.

Indexed as

Alternative SplicingBase SequenceDNA PrimersExonsGene ExpressionHumansModels, GeneticMolecular Sequence DataOctamer Transcription Factor-3OligonucleotidesPseudogenesReverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA ProbesSequence Homology, Nucleic AcidDNA Primerslocked nucleic acidOctamer Transcription Factor-3OligonucleotidesPOU5F1 protein, humanRNA, MessengerRNA Probes

Identifiers

PMID21265047
PMCPMC3030960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.